American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
Hodgson
Stephen F
SF
Watts
Nelson B
NB
Bilezikian
John P
JP
Clarke
Bart L
BL
Gray
T Kenney
TK
Harris
David W
DW
Johnston
C Conrad
CC
Kleerekoper
Michael
M
Lindsay
Robert
R
Luckey
Marjorie M
MM
McClung
Michael R
MR
Nankin
Howard R
HR
Petak
Steven M
SM
Recker
Robert R
RR
D000058:Accidental Falls / Q000517:prevention & control; D000368:Aged; D015519:Bone Density; D001846:Bone Development; D016723:Bone Remodeling; D001842:Bone and Bones / Q000293:injuries; D002116:Calcitonin / Q000008:administration & dosage / Q000009:adverse effects; D002136:Calcium, Dietary / Q000008:administration & dosage; D000075202:Contraindications; D019587:Dietary Supplements; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects; D004704:Endocrinology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D015444:Exercise; D005260:Female; D050723:Fractures, Bone / Q000175:diagnosis / Q000209:etiology; D006620:Hip Fractures / Q000209:etiology; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy*; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage / Q000009:adverse effects; D019379:Teriparatide / Q000008:administration & dosage / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage
D002136:Calcium, Dietary; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D019379:Teriparatide; D014807:Vitamin D; D002116:Calcitonin